The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPoolbeg Pharma Share News (POLB)

Share Price Information for Poolbeg Pharma (POLB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.10
Bid: 12.90
Ask: 13.30
Change: -0.10 (-0.76%)
Spread: 0.40 (3.101%)
Open: 13.20
High: 13.20
Low: 13.05
Prev. Close: 13.20
POLB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Enwell shuts down operations; i3 ups oil production

Thu, 24th Feb 2022 21:57

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Caledonia Mining Corporation PLC - Jersey, UK-based gold producer with operations in Zimbabwe - Signs zero cost contract to hedge 25% of its 2022 target production at the Blanket mine in Zimbabwe. The contract is a cap and collar hedging contract for 20,000 ounces of gold. The contract runs over a period of 5 months from March to July. It has a cap of USD1,940 and a collar of USD1,825.

----------

Enteq Technologies PLC - Ascot, England-based energy services technology supplier - Says sales and orders since September 30 have continued in-line with its previous interim update. Company says this is primarily due to an increase in active drilling rigs and tightening of surplus capacity in North America. Notes continued progress at the Saber field-testing and development programme.

----------

Caerus Mineral Resources PLC and Bezant Resources PLC - London-based mining companies - Jointly report that independent laboratory assays have been received for both dump sampling and drilling at the Troulli, Kokkinapetra and Anglisides copper-gold joint-venture projects in Cyprus. At the Troulli project, stock pile sampling returns an average grade of 1.2% copper and positive copper and gold mineralisation drill results outside main the Troulli deposit area. At the Kokkinapetra project, drilling of a 1.5 kilometre strike length returns "extremely encouraging" drill results including 0.85% copper equivalent over 28.10 metres from surface and 1.0 grams per tonne of gold over 10.8 metres. Returns equally encouraging results at Anglesides project with a peak intercept of 1.2% copper equivalent over 40 metres from surface.

----------

Live Co Group PLC - Surrey, England-based live events and entertainment company - Signs contract for its first live show since the start of the pandemic. "Bricklive in the Park" show is to take place in August and, the company says, may potentially be multi-year. Does not disclose the financial details of the contract but says revenue will be generated through ticket sales, retail stands and sponsorship.

----------

Block Energy PLC - London-based oil and gas company focused in Georgia - Reports production from well JKT-01Z continues at a rate of 310 barrels of oil equivalent per day, comprising of 182 barrels of oil per day and 21,800 cubic metres of gas per day. Adds that drilling at well WR-B1 is "advanced".

----------

Braime Group PLC - Leeds, England-based metal presswork manufacturer - Says that in the course of construction at its freehold property in Leeds, builders have encountered an unmarked well which has caused delays to the work. Completion of the warehouse is now expected in the summer. Construction is for the redevelopment of the rear of the property.

----------

Mila Resources PLC - London-based gold company focused on Australia - Intersects 7.4 metres of sulphide mineralisation from 178 metres from its first drill hole at the Kathleen Valley gold project in Western Australia. Says diamond core hole KVRD024 drilled to twin the gold-silver-zinc rich reverse circulation hole KVRC019 and returned 10 metres at 8.4 grams per tonne of gold, 14 grams per tonne of silver and 0.9% zinc from 165 to 175 metres.

----------

Costain Group PLC - Maidenhead, England-based construction and engineering company - Reaches final settlement with National Grid regarding the legacy Peterborough and Huntingdon contract. The settlement brings an end to the dispute after the contract was terminated in June 2020 and prevents any further claims under the contract. Constain makes a final payment of GBP43.4 million to National Grid.

----------

Seeing Machines Ltd - Canberra, Australia-based AI technology company - Will deliver its eye-tracking solution to Air Ambulance Victoria in Australia through a AUD1 million 10-year contract. Company says the technology aims to reduce the risk of pilot fatigue and will be retrofitted into Air Ambulance Victoria's aircraft. The first installation will be operational by the end of the year, Seeing Machines says, with the remaining three aircraft scheduled for 2023.

----------

Tertiary Minerals PLC - Cheshire, England-based precious metals mining company - Says drill pad construction and site access is complete at its Pyramid silver-gold project in Nevada, US. Surface mineralisation has been shown to extend over a strike extent of at least 530 metres at the North Ruth target, with grades as high as 595 grams per tonnes of silver and 0.66 grams per tonne of gold intersected in exploration trenches, company says. Adds that Envirotech Drilling LLC will mobilise and begin drilling at the site in the second week of March.

----------

Diversified Energy Company PLC - Alabama, US-based oil and gas company focused in the US - Closes a USD160 million sustainability-linked asset backed securitisation of certain Barnett shale assets in Texas. The assets were previously pledged as collateral under the company's revolving credit facility. The company says it will use the asset backed securitisation proceeds to reduce its revolving credit facility borrowings.

----------

Eco Atlantic Oil & Gas Ltd- London-based oil and gas company focused in Africa - Says that Solear Ltd has sold the Kozani project in Greece for EUR1.8 million to London-based investment company Nepcoe Capital Partners Ltd in partnership with PowerChina New Energy Power Co Ltd, a Chinese state-owned construction and renewable energy infrastructure company. Company says the transaction enables the re-payment of this consideration to Eco Atlantic as a result of a shareholder loan given by Eco Atlantic to Solear in January 2021. Adds that the disposal represents a 25% margin on the initial acquisition price of the Kozani project.

----------

Capital Ltd - Mauritius-based drilling services contractor - Completes share buyback programme originally announced on January 4. The company purchases 2 million shares for a total cost of USD2.5 million.

----------

LXi REIT PLC - London-based real estate investment trust - Announces forward funding property acquisitions totalling GBP26 million. The acquisitions are funded by the company's GBP250 million equity capital raise. Says it reflects an 5% accretive net initial yield. For each of these forward funding acquisitions, LXi says full planning consent is in place and that the agreements for lease have been exchanged. The properties are a Tesco PLC foodstore, a Home Bargains store, and Co-Operative Food Group Ltd leased store.

----------

Tirupati Graphite PLC - Mumbai-based graphite and graphene company - Announces that Tirupati Speciality Graphite Private Ltd, a company with which Tirupati has a 100% acquisition agreement, has signed an exclusive UK marketing and distribution agreement with Minralis Ltd for its graphite-based CarboflameX and GrafEN 45545 products. The first order from Minralis for 66 tonnes of CarboflameX, valued at USD200,000, is expected to be completely delivered by mid-March.

----------

Poolbeg Pharma PLC - London-based pharmaceutical company - Signs agreement with OneThree Biotech Inc, a New York-based drug discovery company, to identify new drug targets and treatments for respiratory syncytial virus. OneThree Biotech's AI analysis tools will be used to identify drug assets which target immune-response pathways, have a higher probability of clinical success and have the potential to prevent and/or treat infectious diseases. The analysis is expected to commence in the first quarter of 2022, with preliminary outputs expected in the second half of the year.

----------

W Resources PLC - London-based tin and gold mining company with projects focused in Spain and Portugal - Says that discussions regarding the fund raise announced on February 15 - expected to be in the form of debt - are progressing well, with the documentation being finalised. Company expects to announce the details of the fundraise in the next few days.

----------

Mast Energy Developments PLC - London-based developer of reserve power generations plants - Says its 100% owned 5 megawatt Bordesley project was successful in securing a 15-year capacity market contract of GBP30.59 per kilowatt per annum. The company says this will result in an increase of GBP105,935 in annual cashflow or a total of GBP1.6 million in additional income over the 15-year period.

----------

i3 Energy PLC - Alberta, Canada-based oil and gas company with operations in the UK and Canada - Reports average production of 18,229 barrels of oil equivalent per day in the fourth quarter of 2021. i3 says this represented a 38% increase from 13,239 boepd the previous quarter and generated revenue of USD57.6 million. Adds that full-year net operating income for 2021 is now forecast to be USD66 million, increasing to USD150.3 million in 2022.

----------

Bluebird Merchant Ventures Ltd - British Virgin Islands-based gold development company focused on Korea - Says it has had productive discussions with Southern Gold with respect to ways that they can be of assistance in progressing its South Korean gold projects to production. Adds it is also in the process of revising its economic model for its South Korean projects to reflect its Kochang project being scheduled towards production.

----------

Forward Partners Group PLC - London-based investment firm - Announces a GBP7.8 million portfolio company valuation uplift. The increase, the company explains, is a consequence of a portfolio company successfully raising a USD25 million A round. Based upon the valuation implied by the fundraising, the company's holding is worth approximately GBP9.5 million which Forward Partners says represents an 8 times increase on its original investment.

----------

Bango PLC - Cambridge, England-based technology company - Says that Hertfordshire, England-based communications company Entel has launched a new Apple Music offer through the Bango Platform. The offer is initially in Chile and is the fourth major content service launched by Entel using the Bango Platform, the company says. Does not disclose financial details of the deal.

----------

Resolution Life Group - Bermuda-based life insurance company - Acquires the Superannuation & Investments business of Melbourne-based life insurance company AIA Australia Ltd for an undisclosed amount. The acquisition increases the company's asset under management and administration by AUD8.2 billion, around USD5.9 billion. AIA's Superannuation & Investment business will be fully integrated into Resolution Life's local business operations.

----------

Enwell Energy PLC - London-based oil and gas company - Shuts down its field and drilling operations at its Mekhediviska-Golotvshinska site, its Svyrydivske and Vasyschevskoye gas and condensate fields and its Svystunivsko-Chervonolutskyi exploration licence in light of Russian military activity in Ukraine.

----------

Wise PLC - London-based financial technology company - Appoints current finance director Kingsley Kemish as interim chief financial officer following CFO Matthew Briers's cycling accident.

----------

By Heather Rydings; heatherrydings@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
21 Dec 2022 19:20

TRADING UPDATES: Atlantis Japan underperforms; Bellevue lowers payout

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
21 Dec 2022 13:37

Poolbeg identifies new drug candidates with OneThree

(Sharecast News) - Biopharmaceutical company Poolbeg Pharma has successfully identified potential new drug candidates from its respiratory syncytial virus (RSV) artificial intelligence (AI) programme with OneThree Biotech, it announced on Wednesday.

Read more
14 Dec 2022 21:54

TRADING UPDATES: Poolbeg acquires license; Afentra expects PSA delay

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
14 Dec 2022 16:14

Poolbeg secures exclusive licence to possible obesity drug tech

(Sharecast News) - Infectious disease-focussed biopharmaceutical company Poolbeg Pharma has acquired an exclusive licence from AnaBio sister company InsuCaps, it announced on Wednesday, to use its patented microencapsulation and nanoencapsulation oral delivery technologies in metabolic syndrome-related diseases, including obesity, pre-diabetes and diabetes.

Read more
2 Dec 2022 19:33

TRADING UPDATES: Time Out eyes Riyadh; MTI Wireless wins deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued this week and not separately reported by Alliance News:

Read more
15 Nov 2022 17:25

Poolbeg Pharma wins funding for oral vaccine development

(Alliance News) - Poolbeg Pharma PLC on Tuesday said it has received funding from the Irish Government to improve the manufacturing, distribution and administration of its oral vaccines.

Read more
8 Nov 2022 13:06

Poolbeg announces 'breakthrough' in AI drug target programme

(Sharecast News) - Infectious disease pharmaceutical developer Poolbeg Pharma announced a "significant breakthrough" in its artificial intelligence (AI) programme with partner OneThree Biotech on Tuesday, through the discovery of novel drug targets for the treatment of respiratory syncytial virus (RSV).

Read more
8 Nov 2022 12:18

IN BRIEF: Poolbeg makes "significant breakthrough" in AI programme

Poolbeg Pharma PLC - London-based clinical stage infectious disease pharmaceutical company - Announces "significant breakthrough" in its artificial intelligence programme with its partner OneThree Biotech Inc, a New York-based drug discovery-focused firm. Says breakthrough is the discovery of novel drug targets for the treatment of respiratory syncytial virus. The identification of these targets allow for the final stages of the programme to start, Poolbeg explains. This will involve the identification of small molecule inhibitors to treat RSV infections. The team is "particularly excited", the firm says, as these include a range of targets for which there are known drugs with existing Phase I safety and tolerability data. Results are expected before the end of 2022.

Read more
4 Oct 2022 14:14

Poolbeg Pharma upbeat on US patent application progress

(Sharecast News) - Infectious disease pharmaceutical company Poolbeg Pharma updated the market on its intellectual property (IP) position around 'POLB 001' on Tuesday, which it described as a small molecule immunomodulator for the treatment of severe influenza.

Read more
4 Oct 2022 10:14

Poolbeg expects formal patent grant soon to treat hypercytokinemia

(Alliance News) - Poolbeg Pharma PLC on Tuesday said that the US Patent & Trademarks Office has indicated that its patent application concerning the use of POLB 001 and its homologues for the treatment of hypercytokinemia is allowable.

Read more
4 Oct 2022 08:46

LONDON MARKET OPEN: Stocks rise as market sentiment recovers

(Alliance News) - Stock prices in London opened sharply higher on Tuesday, lifted by more positive market sentiment following the UK government's tax U-turn, as well as some positive trading updates.

Read more
4 Oct 2022 07:52

LONDON BRIEFING: Pound, oil, gold up; Truss vows fiscal responsibility

(Alliance News) - Stocks in London are called higher on Tuesday, as the market watches closely for further clues regarding the UK's economic direction.

Read more
27 Sep 2022 06:59

IN BRIEF: Poolbeg Pharma teams up for Melioidosis vaccine

Poolbeg Pharma PLC - London-based pharmaceutical company - On Wednesday reported it a signed an in-license agreement for the development of a Melioidosis vaccine candidate with University College Dublin. Melioidosis is an infectious disease spread by a bacterium in contaminated soil or water. It has a minimum fatality rate of around 10% and no vaccine for the disease exists. Poolbeg's late preclinical stage vaccine candidate has the name POLB 003. It is being developed following several years of research.

Read more
21 Sep 2022 16:18

Poolbeg inks exclusive deal for melioidosis vaccine candidate

(Sharecast News) - Clinical-stage infectious disease pharmaceutical company Poolbeg Pharma has signed an exclusive licence agreement with University College Dublin (UCD), it announced on Wednesday, for a late preclinical-stage vaccine candidate for melioidosis.

Read more
6 Sep 2022 14:04

IN BRIEF: Poolbeg shares rises on narrowed loss, strong pipeline

Poolbeg Pharma PLC - London-based pharmaceutical company - In the six months ended June 30, narrows its pretax loss to GBP1.7 million from GBP2.3 million loss the year prior. Does not post a revenue figure, unchanged from the previous year. Research & development expenses rise to GBP657,000 from GBP414,000. Notes "significant" progress on POLB 001, its treatment for severe influenza. Expects outputs from its respiratory syncytial virus and influenza artificial intelligence programmes by the end of 2022 and the second quarter of 2023, respectively. Adds it has "strong financial resources available to progress its products and platforms."

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.